Search

Your search keyword '"Okumura, Nobumasa"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Okumura, Nobumasa" Remove constraint Author: "Okumura, Nobumasa"
37 results on '"Okumura, Nobumasa"'

Search Results

2. Characteristics of preventive intervention acceptance for international travel among clients aged 60 years and older from a Japanese multicenter pretravel consultation registry

3. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees

4. Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis against mpox in a High-Risk Population: An Open-Label Randomized Trial

5. Relapse of toxocariasis after completion of four-week treatment with albendazole.

7. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults

9. Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan

10. Autopsy of tetanus with foot gangrene as portal of entry

12. Characterization of an EG.5.1 clinical isolate in vitro and in vivo

14. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study

15. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox

16. Clinical Characteristics and Outcomes Among Travelers With Severe Dengue

17. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo

18. Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study

19. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study (Preprint)

21. Treatment with tecovirimat of the first two cases of monkeypox in Japan

25. Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan

27. Two Cases of Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections Caused by the Omicron Variant (B.1.1.529 Lineage) in International Travelers to Japan

31. Prevalence of HIV-1 Integrase Polymorphisms and Drug Resistance Mutations in Newly Diagnosed Individuals with HIV-1 in the Tokai Area

32. Trends in Transmitted Drug Resistance and Prevalence of Non-B Subtype in Newly Diagnosed Individuals with HIV-1 in the Tokai Area

35. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitroand in vivo

36. Time from admission to the onset of methicillin-resistant Staphylococcus aureus bacteremia in a single acute care hospital in Japan.

37. The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics.

Catalog

Books, media, physical & digital resources